Henrik Asmussen

Commercial Executive | Biopharma | Strategic Advisor | Consultant | Leadership Coaching

📍 Zurich, Switzerland🔄 Updated September 2026💼 3 investments📅 9 years investing🗓 Last invested Mar 2018
Angel investor🌍 Switzerland
3
Total investments
0
Early stage
0
Mid stage
0
Late stage
9y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member Chapter Doing Business in Switzerland
Jul 2017
The Swiss-American Chamber of Commerce plays a vital and active role in assisting Swiss companies in the United States and U.S. companies in Switzerland to expand their business. The Swiss-American Chamber of Commerce is a not-for-profit organization. The Chamber 1. Promotes and facilitates better business relations between the U.S. and Switzerland. 2. Provides essential information about doing business in these markets. 3. Brings business leaders together to facilitate contacts and provide platforms for networking in both countries. 4. Represents the mutual interests of members and takes action to further their interests. 5. Facilitates the mobility of member firms and their employees in both countries. 6. Promotes both countries as advantageous places to do business. 7. Fosters good corporate citizenship to benefit the communities in which members do business.
Experience · 5 entries
All (5)
Investments (3)
Board (3)
2018
Interpharma
Board Member
Mar 2018
Board Member
Mar 2018
Interpharma is the association of research-based pharmaceutical companies in Switzerland and was founded in 1933 as an association based in Basel. Historically, Interpharma was an establishment of Switzerland’s big research-based pharmaceutical companies. With the opening-up over the last few years and the resulting sharp increase in membership to its present number of 24 research-based pharmaceutical companies, Interpharma has grown to become the umbrella association of research-based pharmaceutical companies in Switzerland. Member firms are Johnson & Johnson, Novartis, Roche, AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Gilead, GlaxoSmithKline, Lilly, Lundbeck, Merck, Merck Sharp & Dohme (MSD), Pfizer, Sanofi, Shire, Takeda, UCB and Vifor. Interpharma is committed to creating conditions conducive to innovation in both Switzerland and abroad so as to promote pharmaceutical research, development and production. It supports all efforts to create a social, economic and political environment that strengthens Switzerland as a centre of pharmaceutical research and production. Therefore, the association is an active partner in national health policy and fosters dialogue through its analyses, studies and other publications and events. Interpharma promotes a greater public understanding of new technologies and methods used in biomedical research and fosters the rigorous protection of intellectual property as an essential precondition for successful pharmaceutical research at the global and national level. It wants to help giving patients access to the latest medical advances as well as to safeguard and promote the development of professional and ethical standards in the research, development and marketing of pharmaceuticals.
2017
Board Member Chapter Doing Business in Switzerland
Jul 2017
The Swiss-American Chamber of Commerce plays a vital and active role in assisting Swiss companies in the United States and U.S. companies in Switzerland to expand their business. The Swiss-American Chamber of Commerce is a not-for-profit organization. The Chamber 1. Promotes and facilitates better business relations between the U.S. and Switzerland. 2. Provides essential information about doing business in these markets. 3. Brings business leaders together to facilitate contacts and provide platforms for networking in both countries. 4. Represents the mutual interests of members and takes action to further their interests. 5. Facilitates the mobility of member firms and their employees in both countries. 6. Promotes both countries as advantageous places to do business. 7. Fosters good corporate citizenship to benefit the communities in which members do business.
2013
Crestor Global Director Europe, Global Product & Portfolio Strategy
Jul 2013
Were transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
Crestor Global Director Europe, Global Product & Portfolio Strategy
Jul 2013
Were transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
Investment activity
2017–2018 · 3 investments
2017120182
Recent (last 2 years)Earlier